首页|原瘤基因激活诱导成熟B细胞恶变的作用机制

原瘤基因激活诱导成熟B细胞恶变的作用机制

扫码查看
目前恶性肿瘤仍然是严重威胁人类生命安全的疾病,肿瘤的发生本质上是由于原瘤基因的激活和抑瘤基因的失活,其中原瘤基因的激活更具有驱动细胞恶性转化的能力.以肿瘤细胞恶变过程中发挥作用的原瘤基因作为药物靶点为当前开发肿瘤药物提供了新思路.近年来多项临床和基础研究表明:原瘤基因及其代谢产物可调节B细胞发育路径,在诱导正常成熟B细胞发展成恶性肿瘤的过程中发挥关键作用.因此,总结在成熟B细胞恶变过程中关键的原瘤基因,明确其在肿瘤发生、发展中的作用机制对临床治疗恶性肿瘤具有重要意义.
Mechanisms of the role of proto-oncogene activation in promoting malignant transformation of mature B cells
Malignant tumors continue to pose a significant threat to human life and safety and their development is primarily due to the activation of proto-oncogenes and the inactivation of suppressor genes.Among these,the activation of proto-oncogenes possesses greater potential to drive the malignant transformation of cells.Targeting oncogenes involved in the malignant transformation of tumor cells has provided a novel approach for the development of current antitumor drugs.Several preclinical and clinical studies have revealed that the development pathway of B cells,and the malignant transformation of mature B cells into tumors have been regulated by oncogenes and their metabolites.Therefore,summarizing the key oncogenes involved in the process of malignant transformation of mature B cells and elucidating the mechanisms of action in tumor development hold significant importance for the clinical treatment of malignant tumors.

proto-oncogene activatedB cell malignant transformationmature B cell neoplasms

周瑞琪、郭姣姣、冯湘玲、周文

展开 >

中南大学基础医学院肿瘤研究所,长沙 410078

中南大学湘雅医院血液科,长沙 410008

中南大学湘雅公共卫生学院,长沙 410006

原瘤基因激活 成熟B细胞恶变 成熟B细胞肿瘤

国家自然科学基金

82130006

2024

中南大学学报(医学版)
中南大学

中南大学学报(医学版)

CSTPCD北大核心
影响因子:1.459
ISSN:1672-7347
年,卷(期):2024.49(1)
  • 64